Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Hemoglobin glycation index and the dynamic progression of cardiometabolic multimorbidity and mortality: a multi-state Markov analysis
Related
- Estimated glucose disposal rate shows the broadest associations with cardiometabolic multimorbidity progression in early cardiovascular–kidney–metabolic stages: a longitudinal cohort study
- Association between C-reactive protein-triglyceride-glucose index and one-year all-cause mortality in patients with cardiometabolic multimorbidity
- Prognostic significance of the hemoglobin glycation index in critically ill patients with and without diabetes: analysis of the MIMIC-IV database
- Treatment burden and cardiometabolic multimorbidity: Implications for the Philippines
- Estimated cardiorespiratory fitness and incident cardiometabolic multimorbidity: findings from three nationally representative cohorts
BibTeX
@article{liu2026hemoglobin,
title = {{Hemoglobin glycation index and the dynamic progression of cardiometabolic multimorbidity and mortality: a multi-state Markov analysis}},
author = {Chang Liu and Wenkai Zhu and Yuzhen Jiang and Wenyue Xu and Qiwen Wu},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-76780-7},
url = {https://www.nature.com/articles/s41598-026-76780-7},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Hemoglobin glycation index and the dynamic progression of cardiometabolic multimorbidity and mortality: a multi-state Markov analysis
AU - Chang Liu
AU - Wenkai Zhu
AU - Yuzhen Jiang
AU - Wenyue Xu
AU - Qiwen Wu
PY - 2026
DA - 2026/10/20
JO - Scientific Reports
DO - 10.1038/s41598-026-76780-7
UR - https://www.nature.com/articles/s41598-026-76780-7
SN - 2045-2322
ER -